 CD79 Antigens
"CD79 Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Components of the B-cell antigen receptor that function in B-cell antigen receptor heavy chain transport to the PLASMA MEMBRANE. They are expressed almost exclusively by B-LYMPHOCYTES and are markers for B-cell NEOPLASMS.
| Descriptor ID |
D051925
|
| MeSH Number(s) |
D12.776.124.790.651.950.500 D12.776.377.715.548.950.500 D12.776.543.750.705.816.821.500
|
| Concept/Terms |
CD79 Antigens- CD79 Antigens
- Antigens, CD79
- CD79 Antigen
- Antigen, CD79
CD79b Antigens- CD79b Antigens
- Antigens, CD79b
- Igbeta Antigen
- Antigen, Igbeta
- CD79b Antigen
- Antigen, CD79b
- Immunoglobulin-Associated Beta Protein
- Immunoglobulin Associated Beta Protein
- B-Cell Antigen Receptor Complex Associated Protein Beta-Chain
- B Cell Antigen Receptor Complex Associated Protein Beta Chain
CD79a Antigens- CD79a Antigens
- CD79a Antigen
- Antigen, CD79a
- Immunoglobulin-Associated Alpha Protein
- Immunoglobulin Associated Alpha Protein
- IgM-Alpha Component
- IgM Alpha Component
- Antigens, CD79a
|
Below are MeSH descriptors whose meaning is more general than "CD79 Antigens".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Blood Proteins [D12.776.124]
- Serum Globulins [D12.776.124.790]
- Immunoglobulins [D12.776.124.790.651]
- Receptors, Antigen, B-Cell [D12.776.124.790.651.950]
- CD79 Antigens [D12.776.124.790.651.950.500]
- Globulins [D12.776.377]
- Serum Globulins [D12.776.377.715]
- Immunoglobulins [D12.776.377.715.548]
- Receptors, Antigen, B-Cell [D12.776.377.715.548.950]
- CD79 Antigens [D12.776.377.715.548.950.500]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, Immunologic [D12.776.543.750.705]
- Receptors, Antigen [D12.776.543.750.705.816]
- Receptors, Antigen, B-Cell [D12.776.543.750.705.816.821]
- CD79 Antigens [D12.776.543.750.705.816.821.500]
Below are MeSH descriptors whose meaning is more specific than "CD79 Antigens".
This graph shows the total number of publications written about "CD79 Antigens" by people in this website by year, and whether "CD79 Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 0 | 2 | 2 | | 1992 | 0 | 2 | 2 | | 1993 | 0 | 2 | 2 | | 1994 | 0 | 1 | 1 | | 1997 | 0 | 2 | 2 | | 1998 | 0 | 1 | 1 | | 1999 | 0 | 2 | 2 | | 2001 | 0 | 4 | 4 | | 2002 | 0 | 4 | 4 | | 2003 | 0 | 2 | 2 | | 2004 | 0 | 2 | 2 | | 2006 | 1 | 0 | 1 | | 2007 | 1 | 0 | 1 | | 2008 | 1 | 0 | 1 | | 2009 | 0 | 1 | 1 | | 2010 | 0 | 1 | 1 | | 2011 | 1 | 0 | 1 | | 2012 | 0 | 2 | 2 | | 2014 | 1 | 0 | 1 | | 2018 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "CD79 Antigens" by people in Profiles.
-
Hobeika E, Dautzenberg M, Levit-Zerdoun E, Pelanda R, Reth M. Conditional Selection of B Cells in Mice With an Inducible B Cell Development. Front Immunol. 2018; 9:1806.
-
Hardy IR, Anceriz N, Rousseau F, Seefeldt MB, Hatterer E, Irla M, Buatois V, Chatel LE, Getahun A, Fletcher A, Cons L, Pontini G, Hertzberg NA, Magistrelli G, Malinge P, Smith MJ, Reith W, Kosco-Vilbois MH, Ferlin WG, Cambier JC. Anti-CD79 antibody induces B cell anergy that protects against autoimmunity. J Immunol. 2014 Feb 15; 192(4):1641-50.
-
RamÃrez J, Dege C, Kutateladze TG, Hagman J. MBD2 and multiple domains of CHD4 are required for transcriptional repression by Mi-2/NuRD complexes. Mol Cell Biol. 2012 Dec; 32(24):5078-88.
-
Khalil AM, Cambier JC, Shlomchik MJ. B cell receptor signal transduction in the GC is short-circuited by high phosphatase activity. Science. 2012 Jun 01; 336(6085):1178-81.
-
O'Neill SK, Getahun A, Gauld SB, Merrell KT, Tamir I, Smith MJ, Dal Porto JM, Li QZ, Cambier JC. Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy. Immunity. 2011 Nov 23; 35(5):746-56.
-
Dhirapong A, Lleo A, Yang GX, Tsuneyama K, Dunn R, Kehry M, Packard TA, Cambier JC, Liu FT, Lindor K, Coppel RL, Ansari AA, Gershwin ME. B cell depletion therapy exacerbates murine primary biliary cirrhosis. Hepatology. 2011 Feb; 53(2):527-35.
-
Hagman J. Conveying the message: identification of Ig-alpha and Ig-beta as components of the B cell receptor complex. J Immunol. 2009 Aug 01; 183(3):1503-4.
-
Li Y, Chen F, Putt M, Koo YK, Madaio M, Cambier JC, Cohen PL, Eisenberg RA. B cell depletion with anti-CD79 mAbs ameliorates autoimmune disease in MRL/lpr mice. J Immunol. 2008 Sep 01; 181(5):2961-72.
-
Jin L, Stolpa JC, Young RM, Pugh-Bernard AE, Refaeli Y, Cambier JC. MHC class II structural requirements for the association with Igalpha/beta, and signaling of calcium mobilization and cell death. Immunol Lett. 2008 Mar 15; 116(2):184-94.
-
Hobeika E, Thiemann S, Storch B, Jumaa H, Nielsen PJ, Pelanda R, Reth M. Testing gene function early in the B cell lineage in mb1-cre mice. Proc Natl Acad Sci U S A. 2006 Sep 12; 103(37):13789-94.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|